Doxazosin Mesylate
Product Images NDC 10544-292

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Doxazosin Mesylate (NDC 10544-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Graphic- 1mg 90s (Label Graphic 1mg 90s)

This is a prescription drug called Doxazosin Mesylate available in tablet form with a strength of 1mg. The drug comes in a pack of 90 tablets. The package insert should be followed for the dosage. It should be stored at a controlled room temperature and kept out of the reach of children. The lot number and expiration date are also provided in the text.*

FDA Label Image

Label Graphic- 4mg 90s (Label Graphic 4mg 90s)

This text is a medication label for Doxazosin Mesylate Tablets at a dosage of 4mg, with 90 tablets per bottle. It includes information on storage recommendations, dosage, and precautions for children. There are also several NDC and MFG numbers, lot numbers, and expiration dates listed.*

FDA Label Image

Doxazosin Mesylate Molecular Structure (Image 01)

FDA Label Image

Table 1. Summary Of Effectiveness Data In Placebo-controlled Trials (Image 02)

This is a table showing effectiveness data in placebo-controlled trials for the treatment of BPH using doxazosin mesylate at various doses. The data includes changes in symptom score and maximum flow rate. Study 1 evaluated the maximum dose of 4mg, study 2 evaluated a fixed dose for 14 weeks, and study 3 evaluated a fixed dose for 12 weeks. The effectiveness was measured using AUA and Modified Boyarsky Questionnaires. The table also indicates that the study was conducted on hypertensive patients with BPH.*

FDA Label Image

Graph: Mean Change In Total Symptom Score From Baseline (Image 03)

The text describes a figure called Figure 1, which displays the mean change in total symptom score from baseline. The X-axis represents the duration of treatment in weeks, and the Y-axis represents the mean change in symptom score. There are data points at weeks 2, 4, 6, 8, 10, 12, and 14.*

FDA Label Image

Graph: Mean Increase In Maximum Urinary Flow Rate (ml/sec) From Baseline (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.